Expression of myogenic regulatory factors in normal and dystrophic mice: Effects of IGF-1 treatment

Biochemical and Molecular Medicine

Volumn 60, Issue 2, 1997, Pages 142-148

  Hsu, H H ^a   Zdanowicz, M M ^b   Agarwal, V R ^c   Speiser, P W ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOGENIC FACTOR; MYOGENIN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; MALE; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; SKELETAL MUSCLE;

ANIMALIA;

EID: 0031127860     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1997.2570     Document Type: Article

References (30)

1. Goldberg A L, Goldberg G E, Dice J F. Regulation of protein synthesis in normal and dystrophic muscle. Pathogenesis of Human Muscular Dystrophys. 1977;Excerpta Medica, Amsterdam. p. 376-385.
2. Goldspink D F, Goldspink G. Age-related changes in protein turnover and ribonucleic acid content of diaphragm muscle of normal and dystrophic hamsters. Biochem J. 162:1977;191-194.
3. Ballard J F, Nield M K, Tomas F M. Effects of insulin on protein synthesis in muscle from normal and dystrophic mice. Muscle Nerve. 6:1987;520-523.
4. Tawa N E, Goldberg A L. Protein and amino acid metabolism in muscle. Engle A G. Myology. 1986;721-743 McGraw-Hill, New York.
5. Turner P R, Westwood T, Regen C M. Increased protein degradation results from elevated calcium levels found in muscle from mdx mice. Nature. 335:1988;735-738.
6. Kang C W, Sunde M L, Swick R W. Characteristics of protein synthesis in skeletal muscle of normal and dystrophic chickens. Biochem Biophys Acta. 802:1984;1-8.
7. Ashmore C R, Summers P J, Lee Y B. Proteolytic enzyme activities and the onset of muscular dystrophy in the chick. Exp Neurol. 94:1986;585-597.
8. Fulks R M, Li J B, Goldberg A L. Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm. J Biol Chem. 250:1975;290-298.
9. Zdanowicz M M, Noyse J, Wingertzahn M A, O'Connor M, Teichberg S, Slonim A E. Effect of insulin-like growth factor I in murine muscular dystrophy. Endocrinology. 136:1995;4880-4886.
10. Vlachopapadopoulou E, Zachwieja J J, Gertner J M, Manzione D, Bier D M, Matthews D E, Slonim A E. Metabolic and clinical response to recombinant human insulin-like growth factor I in myotonic dystrophy - A clinical research center study. J Clin Endocrinol Metab. 80:1995;3715-3723.
11. Ewton D Z, Falen S L, Florini M R. The type II IGF receptor has low affinity for IGF-I analogs: Pleiotypic actions of IGFs on myoblasts are apparently mediated by the type I receptor. Endocrinology. 120:1987;115-124.
12. Liu J-P, Baker J, Perkins A S, Robertson E J, Efstratiatis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type 1 IGF receptor (IGF1r). Cell. 75:1993;59-72.
13. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart T A. IGF-I is required for normal embryonic growth in mice. Genes Dev. 7:1993;2609-2617.
14. Rosenthal S M, Cheng Z Q. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc Natl Acad Sci USA. 92:1995;10307-10311.
15. Florini J R, Ewton D Z, Roof S L. Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol Endocrinol. 5:1991;718-724.
16. Weintraub H. The MyoD family and myogenesis: Redundancy, networks, and thresholds. Cell. 75:1993;1241-1244.
17. Sargent T D, Jamrich M, Dawid I B. Cell interactions and the control of gene activity during early development ofXenopus laevis. . Dev Biol. 114:1986;238-246.
18. Rhodes S J, Konieczny S F. Identification of MRF4: A new member of the muscle regulatory factor gene family. Genes Dev. 3:1989;2056-2061.
19. Braun T, Buschhasusen-Denker G, Bober E, Tannich E, Arnold H H. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J. 8:1989;701-709.
20. Davis R L, Weintraub H, Lassar A B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 51:1987;987-1000.
21. Edmondson D G, Olson E N. A gene with homology to themyc. Genes Dev. 3:1989;628-640.
22. Souaze R, Ntodou-Thome A, Tran C Y, Rostene W, Forgez P. Quantitative RT-PCR: Limits and accuracy. Biotechniques. 21:1996;280-285.
23. Murphy L D, Herzog C E, Rudick J B, Fojo A T, Bates S E. Use of polymerase chain reaction in the quantitation ofmdr. Biochemistry. 29:1990;10351-10356.
24. Fryburg D A. Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism. Am J Physiol. 267:1994;E331-E336.
25. Megeney L A, Kablar B, Garrett K, Anderson J E, Rudnicki M A. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10:1996;1173-1183.
26. Bhagwati S, Ghatpande A, Shafiq S A, Leung B. In situ hybridization analysis for expression of myogenic regulatory factors in regenerating muscle of mdx mouse. J Neuropathol Exp Neurol. 55:1996;509-514.
27. Rudnicki M A, Jaenisch R. The MyoD family of transcription factors and skeletal myogenesis. BioEssays. 17:1995;203-209.
28. Florini J R, Ewton D Z, Coolican S A. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev. 17:1996;481-517.
29. Mendell J R, Sahenk Z, Prior T W. The childhood muscular dystrophies: Diseases sharing a common pathogenesis of membrane instability. J Child Neurol. 10:1995;150-159.
30. Davies K E, Tinsley J M, Blake D J. Molecular analysis of Duchenne muscular dystrophy: Past, present and future. Ann NY Acad Sci. 758:1995;287-296.